GB941371A - Injectable pharmaceutical preparations comprising 6ª -fluoroprednisolone and/or its 21-acetate - Google Patents

Injectable pharmaceutical preparations comprising 6ª -fluoroprednisolone and/or its 21-acetate

Info

Publication number
GB941371A
GB941371A GB598760A GB598760A GB941371A GB 941371 A GB941371 A GB 941371A GB 598760 A GB598760 A GB 598760A GB 598760 A GB598760 A GB 598760A GB 941371 A GB941371 A GB 941371A
Authority
GB
United Kingdom
Prior art keywords
fluoroprednisolone
acetate
pharmaceutical preparations
vitamins
injectable pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB598760A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of GB941371A publication Critical patent/GB941371A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Injectable sterile aqueous suspensions comprise as essential active ingredient: 6a -fluoroprednisolone, which may be used in the form of the hydrate, and/or 6a -fluoroprednisolone-21-acetate and preferably contain about 2 to 60 mg./ml. of the active material. Optional ingredients include conventional preservatives, buffers, isotonic and suspending agents and, as complementary active ingredients there are mentioned antibiotics, e.g. neomycin, the penicillins, novobiocin, bacitracin, streptomycin, chloramphenicol, erythromycin, tetracycline, thiocymetin and polymyxin and vitamins, e.g. Vitamins A and B, riboflavin, pyridoxins, ascorbic acid and Vitamin B12. Specification 699,709 is referred to.
GB598760A 1959-03-17 1960-02-19 Injectable pharmaceutical preparations comprising 6ª -fluoroprednisolone and/or its 21-acetate Expired GB941371A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US79983759A 1959-03-17 1959-03-17

Publications (1)

Publication Number Publication Date
GB941371A true GB941371A (en) 1963-11-13

Family

ID=25176887

Family Applications (1)

Application Number Title Priority Date Filing Date
GB598760A Expired GB941371A (en) 1959-03-17 1960-02-19 Injectable pharmaceutical preparations comprising 6ª -fluoroprednisolone and/or its 21-acetate

Country Status (1)

Country Link
GB (1) GB941371A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103301466A (en) * 2013-06-26 2013-09-18 河北康润医疗器械有限公司 Hydroprednisone injection composition and preparation method thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103301466A (en) * 2013-06-26 2013-09-18 河北康润医疗器械有限公司 Hydroprednisone injection composition and preparation method thereof

Similar Documents

Publication Publication Date Title
DE3271829D1 (en) An allergen dry powder composition and process for its preparation
GB984464A (en) Therapeutic compositions comprising bromelain
GB946086A (en) Parenteral aqueous solutions of fat-soluble vitamins
GB941371A (en) Injectable pharmaceutical preparations comprising 6ª -fluoroprednisolone and/or its 21-acetate
GB1038415A (en) Cosmetic preparations containing albumins
GB562778A (en) Improvements in or relating to the packaging of friable tablets
NL170852C (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS AND PROCESS FOR THE PREPARATION OF ANTI-INFLAMMATIC ACTIVE P-ISOINDOLINYLPHENYLACACIC ACID AND ITS DERIVATIVES.
GB1001314A (en) Pharmaceutical preparations for combating parasitic helminths
GB1137591A (en) Medicine for the treatment of infections and allergies by nasal administration
GB1072359A (en) Pyrazolone derivatives and pharmaceutical compositions containing them
CA503535A (en) Method for the production of stable concentrates of fat-soluble vitamins, provitamins or similar physiologically active substances in the form of dry powders, and such powders
GB1243401A (en) Pharmaceutical antiviral compositions
GB992956A (en) Pharmaceutical preparations containing pyrrolidone carboxylic acid and salts and esters thereof
GB976096A (en) Pharmaceutical compositions
GB1246315A (en) Pharmaceutical compositions
GB709088A (en) Anti-bacterial therapeutic preparations containing penicillin
AU255425B2 (en) Derivatives of 10, 11-dihydrodibendz azepine and pharmaceutical preparations thereof
GB899059A (en) Improvements in or relating to therapeutic compositions containing a pyridine derivative
AU1152261A (en) Derivatives of 10, 11-dihydrodibendz azepine and pharmaceutical preparations thereof
ZA711290B (en) Novel 16-methylene-9beta,10alpha steroid compounds,pharmaceutical preparations which contain the novel compounds as active ingredients,and methods of producing the said compounds and preparations
GB908634A (en) Pharmaceutical compositions containing pararosaniline or derivatives thereof
AU260990B2 (en) Pharmacologically active 2-thenyl-guanidine derivatives, their preparation, and pharmaceutical compositions thereof
AU238320B2 (en) Improvements in and relating to prolonged acting pharmaceutical preparations for peroral administration
AU1643662A (en) Pharmacologically active 2-thenyl-guanidine derivatives, their preparation, and pharmaceutical compositions thereof
AU265043B2 (en) New derivatives of pyrazine, process of preparing thesame and pharmaceutical preparations containing them